These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 18359978)
1. CDH11 expression is associated with survival in patients with osteosarcoma. Nakajima G; Patino-Garcia A; Bruheim S; Xi Y; San Julian M; Lecanda F; Sierrasesumaga L; Müller C; Fodstad O; Ju J Cancer Genomics Proteomics; 2008; 5(1):37-42. PubMed ID: 18359978 [TBL] [Abstract][Full Text] [Related]
2. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Laverdiere C; Hoang BH; Yang R; Sowers R; Qin J; Meyers PA; Huvos AG; Healey JH; Gorlick R Clin Cancer Res; 2005 Apr; 11(7):2561-7. PubMed ID: 15814634 [TBL] [Abstract][Full Text] [Related]
3. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma. Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779 [TBL] [Abstract][Full Text] [Related]
4. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma. Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943 [TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma. Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma. Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921 [TBL] [Abstract][Full Text] [Related]
7. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Wang Z; Cai H; Lin L; Tang M; Cai H Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma. Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275 [TBL] [Abstract][Full Text] [Related]
10. The expression of CRM1 is associated with prognosis in human osteosarcoma. Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467 [TBL] [Abstract][Full Text] [Related]
11. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. Look AT; Douglass EC; Meyer WH N Engl J Med; 1988 Jun; 318(24):1567-72. PubMed ID: 3163773 [TBL] [Abstract][Full Text] [Related]
12. Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome. Sulzbacher I; Birner P; Dominkus M; Pichlhofer B; Mazal PR Pathology; 2010 Dec; 42(7):664-8. PubMed ID: 21080877 [TBL] [Abstract][Full Text] [Related]
13. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma. Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860 [TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas. Park HR; Min K; Kim HS; Jung WW; Park YK Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723 [TBL] [Abstract][Full Text] [Related]
15. COPS3 amplification and clinical outcome in osteosarcoma. Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities. Guimarães AP; Rocha RM; da Cunha IW; Guimarães GC; Carvalho AL; de Camargo B; Lopes A; Squire JA; Soares FA Eur J Cancer; 2010 Dec; 46(18):3307-15. PubMed ID: 20594821 [TBL] [Abstract][Full Text] [Related]
17. Ezrin expression predicts survival in stage IIB osteosarcomas. Kim MS; Song WS; Cho WH; Lee SY; Jeon DG Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802 [TBL] [Abstract][Full Text] [Related]
18. Tenascin-C as a prognostic biomarker in osteosarcoma? Xiong W; Niu PY; Zhu WT; Chen J Chin Med J (Engl); 2009 Nov; 122(22):2737-43. PubMed ID: 19951606 [TBL] [Abstract][Full Text] [Related]
19. Expression of heat shock proteins in osteosarcomas. Moon A; Bacchini P; Bertoni F; Olvi LG; Santini-Araujo E; Kim YW; Park YK Pathology; 2010; 42(5):421-5. PubMed ID: 20632817 [TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma. Deng Z; Niu G; Cai L; Wei R; Zhao X Biomed Res Int; 2013; 2013():496193. PubMed ID: 23971040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]